Dr. Lovell Allan Jones
Dr. Lovell Allan Jones received his doctorate in 1977 in the field of zoology with an emphasis in endocrinology and tumor biology from the University of California, Berkeley. During his training Dr. Jones was a National Institutes of Health (NIH) pre-doctoral trainee and a Ford Foundation Fellow at the UC Berkeley’s Cancer Research Laboratory.
After receiving his doctorate, Dr. Jones joined the Reproductive Endocrinology Center at the University of California San Francisco (UCSF) as an NIH Postdoctoral Fellow under the mentorship of Dr. Pentti Siiteri. Before joining the Department of Gynecologic Oncology at University of Texas M. D. Anderson Cancer Center (UTMDACC) in 1980, Dr. Jones served as an Instructor in the Departments of Physiology and Obstetrics, Gynecology & Reproductive Sciences at UCSF. Dr. Jones is presently the director of the Congressionally mandated Center for Research on Minority Health in the Department of Health Disparities Research in the division of Cancer Prevention and Population Sciences at The University of Texas M. D. Anderson Cancer Center. He is also the Founding Co-Chair of the Intercultural Cancer Council, the nation’s largest multicultural health policy group focused on minorities, the medically underserved and cancer. He has edited “Minorities & Cancer,” one of the few comprehensive textbooks on this subject. He is the founding chair of Biennial Symposium Series on Minorities and Medically Underserved and Cancer,” the nation’s largest multicultural conference which provides a forum for exchanging the latest scientific and treatment information. Dr. Jones also has spearheaded regional hearings on cancer and the poor for the American Cancer Society.
From 1989 to 1995, Dr. Jones was Co-Principal Investigator of the National Black Leadership Initiative on Cancer, the first major minority outreach project sponsored by the National Cancer Institute. He has served on the board of directors of the National Coalition for Cancer Survivorship, the National Advisory Environmental Health Sciences Council of the National Institutes of Health (NIH), and the Prostate Health Council of the American Foundation for Urologic Diseases. In 1991, Dr. Jones chaired the Training Session of the Strategic Fact-Finding Meetings on Minority Health and Training in Biomedical Sciences for the Office of the Associate Director for Research on Minority Health (now the Center for Minority Health & Health Disparities) at the NIH. A co-author of the congressional resolution that designated the third week in April as “National Minority Cancer Awareness Week,” Dr. Jones was honored in May 2000 on the ßoor of the U.S. House of Representatives for his work addressing health disparities among the underserved.
Dr. Jones has served on the Breast Cancer Integration Panel for the Department of Defense and has published over 100 scientific articles on subjects ranging from hormonal carcinogenesis to health policy. His work with estrogen has led to major Þndings, including the discovery that compounds labeled as weak environmental estrogens may cause adverse effects when exposure occurs during a critical time of development. Because of these results, researchers have begun to rethink when they define environmental estrogens as weak.